Vanguard Group’s Alzamend Neuro ALZN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-78,545
| Closed | -$31K | – | 4351 |
|
2024
Q2 | $31K | Hold |
78,545
| – | – | ﹤0.01% | 4330 |
|
2024
Q1 | $78.5K | Hold |
78,545
| – | – | ﹤0.01% | 4263 |
|
2023
Q4 | $69.9K | Sell |
78,545
-1,956,708
| -96% | -$1.74M | ﹤0.01% | 4343 |
|
2023
Q3 | $482K | Sell |
2,035,253
-1,999
| -0.1% | -$474 | ﹤0.01% | 4061 |
|
2023
Q2 | $1.04M | Hold |
2,037,252
| – | – | ﹤0.01% | 3885 |
|
2023
Q1 | $866K | Sell |
2,037,252
-555,620
| -21% | -$236K | ﹤0.01% | 3965 |
|
2022
Q4 | $1.46M | Sell |
2,592,872
-1,502,903
| -37% | -$849K | ﹤0.01% | 3782 |
|
2022
Q3 | $4.87M | Buy |
4,095,775
+4,035,028
| +6,642% | +$4.8M | ﹤0.01% | 3342 |
|
2022
Q2 | $53K | Buy |
+60,747
| New | +$53K | ﹤0.01% | 4581 |
|